©The Author(s) 2026.
World J Clin Oncol. Jan 24, 2026; 17(1): 114012
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.114012
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.114012
Table 3 Weighted baseline characteristics by quartiles of the Ferritin index
| Ferritin index | Quartile 1 (1.89-83.13) | Quartile 2 (83.18-129.21) | Quartile 3 (130.65-175.25) | Quartile 4 (175.68-378.29) | Statistic | P value |
| Age | 44.31 ± 10.51 | 45.90 ± 11.01 | 46.95 ± 9.46 | 47.66 ± 8.70 | F = 1.94 | 0.122 |
| TAM | 92.71 ± 11.71 | 96.23 ± 14.10 | 90.62 ± 11.22 | 91.41 ± 14.77 | F = 0.56 | 0.645 |
| TSGF | 52.11 ± 15.94 | 52.25 ± 18.33 | 51.70 ± 17.98 | 54.60 ± 18.68 | F = 0.42 | 0.736 |
| AST | 22.16 ± 7.34 | 23.52 ± 26.25 | 23.61 ± 9.15 | 23.78 ± 14.54 | F = 0.19 | 0.902 |
| ALT | 22.07 ± 13.33 | 29.38 ± 55.16 | 27.47 ± 18.35 | 27.73 ± 23.93 | F = 0.88 | 0.453 |
| ALP | 75.24 ± 35.52 | 75.57 ± 23.04 | 74.70 ± 17.44 | 83.76 ± 42.89 | F = 1.47 | 0.222 |
| LDH | 175.75 ± 46.90 | 167.67 ± 45.76 | 173.61 ± 40.56 | 179.49 ± 51.28 | F = 0.93 | 0.428 |
| GGT | 27.34 ± 25.41 | 36.67 ± 50.42 | 37.54 ± 39.92 | 54.94 ± 146.71 | F = 1.63 | 0.182 |
| 5-NT | 5.66 ± 4.42 | 6.24 ± 5.18 | 6.39 ± 4.82 | 6.94 ± 7.87 | F = 0.67 | 0.571 |
| GPDA | 70.79 ± 20.37 | 65.42 ± 25.22 | 72.53 ± 23.03 | 74.70 ± 28.84 | F = 2.11 | 0.099 |
| ADA | 13.85 ± 7.51 | 15.42 ± 14.51 | 16.90 ± 18.88 | 13.91 ± 9.46 | F = 0.93 | 0.426 |
| MAO | 4.71 ± 2.50 | 4.78 ± 2.00 | 5.30 ± 2.58 | 5.12 ± 2.72 | F = 1.02 | 0.385 |
| NSE | 2.07 ± 1.30 | 2.64 ± 1.61 | 2.88 ± 2.08 | 2.88 ± 2.51 | F = 3.55 | 0.015a |
| CEA | 1.13 ± 0.79 | 1.57 ± 2.22 | 1.36 ± 1.07 | 1.58 ± 1.43 | F = 1.91 | 0.127 |
| AFP | 1.28 ± 1.13 | 1.94 ± 2.91 | 2.01 ± 2.12 | 1.71 ± 1.76 | F = 2.29 | 0.078 |
| Tumor stage (%) | - | 0.838 | ||||
| I | 0 | 0 | 0 | 0 | ||
| II | 5.06 | 6.10 | 4.94 | 5.13 | ||
| III | 54.43 | 54.88 | 54.32 | 42.31 | ||
| IVa | 36.71 | 34.15 | 35.80 | 43.59 | ||
| IVb | 3.80 | 4.88 | 4.94 | 8.97 | ||
| Gender (%) | χ² = 44.94 | < 0.001a | ||||
| Male | 41.76 | 76.92 | 82.42 | 76.92 | ||
| Female | 58.24 | 23.08 | 17.58 | 23.08 | ||
| 3-year survivors (%) | χ² = 34.13 | < 0.001a | ||||
| Death | 3.30 | 29.67 | 31.87 | 38.46 | ||
| Survival | 96.70 | 70.33 | 68.13 | 61.54 | ||
| 5-year survivors (%) | χ² = 97.78 | < 0.001a | ||||
| Death | 8.79 | 62.64 | 57.14 | 78.02 | ||
| Survival | 91.21 | 37.36 | 42.86 | 21.98 |
- Citation: Tang Q, Wu Y, Chen L, Jia QY, Tang FQ. Ferritin as a novel predictive index for nasopharyngeal carcinoma survival and therapeutic efficacy of different chemotherapy regimens. World J Clin Oncol 2026; 17(1): 114012
- URL: https://www.wjgnet.com/2218-4333/full/v17/i1/114012.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i1.114012